Cargando…
Dulaglutide and Insulin: How Can the AWARD Studies Help Guide Clinical Practice?
The glucagon-like peptide 1 receptor agonist (GLP-1RA) dulaglutide has many characteristics to recommend it both as a second-line agent and as an alternative to or in combination with insulin. This commentary summarises recent updates to diabetes management guidelines regarding the use of GLP-1RAs s...
Autor principal: | MacIsaac, Richard J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376989/ https://www.ncbi.nlm.nih.gov/pubmed/32564337 http://dx.doi.org/10.1007/s13300-020-00863-5 |
Ejemplares similares
-
How can clinical research help our understanding of trastuzumab-related cardiotoxicity?
por: Lyons, Tomás G., et al.
Publicado: (2015) -
All bleeding stops: how we can help...
por: Riordan, William P, et al.
Publicado: (2010) -
How Canada can help global adolescent health mature
por: Vandermorris, Ashley, et al.
Publicado: (2017) -
How can behavioural science help us design better trials?
por: Gillies, Katie, et al.
Publicado: (2021) -
How can a high-quality genome assembly help plant breeders?
por: Benevenuto, Juliana, et al.
Publicado: (2019)